PV Loop & Coarctation Study
Running, not enrolling
Conditions studied: Coarctation of Aorta
In brief
Coarctation of the aorta accounts for 4-7% of all congenital heart disease. While stent therapy, when feasible, is the standard of care for coarctation, it may not completely improve the work (and afterload) of the heart due to its effects on the elasticity of the aorta. This study will provide the information needed to understand the effects of current management on the cardiac mechanics and work.
Key facts
- Study ID
- NCT05362721
- Run by
- University of Minnesota
- People needed
- 21
- Starts
- 2019-06-04
- Expected to finish
- 2026-12-31
- Last updated by the study team
- 2026-04-08
Who can join
Age: 6 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Children 6 years of age and older and adults of all races and both sexes referred for elective cardiac catheterization and stent therapy for coarctation
- Those who provide informed consent for study participant.
You may not qualify if…
- Children who undergo other interventions in addition to the coarctation
- Children with single ventricle physiology.
- Renal impairment
- Participant unwilling to sign a consent form.
Where it is running
- Children's Hospital of Los Angeles — Los Angeles, California, United States
- Children's Hospital of Boston — Boston, Massachusetts, United States
- Helen DeVos Children's Hospital — Grand Rapids, Michigan, United States
- University of Minnesota — Minneapolis, Minnesota, United States
- Children's Mercy Hospital — Kansas City, Missouri, United States
- Cincinnati Children's Hospital — Cincinnati, Ohio, United States
- University of Texas-Southwestern — Dallas, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.